The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease-Reference-Cited by-同舟云学术

The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease

Published:2011-11-16 Issue:2 Volume:340 Page:404-421
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Jones Carrie K.,Bubser Michael,Thompson Analisa D.,Dickerson Jonathan W.,Turle-Lorenzo Nathalie,Amalric Marianne,Blobaum Anna L.,Bridges Thomas M.,Morrison Ryan D.,Jadhav Satyawan,Engers Darren W.,Italiano Kimberly,Bode Jacob,Daniels J. Scott,Lindsley Craig W.,Hopkins Corey R.,Conn P. Jeffrey,Niswender Colleen M.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference42 articles.

1. Complex Deficits on Reaction Time Performance following Bilateral Intrastriatal 6-OHDA Infusion in the Rat

2. Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism

3. Immunohistochemical localization of subtype 4a metabotropic glutamate receptors in the rat and mouse basal ganglia

4. Modification of dopamine and norepinephrine metabolism in the rat brain by monoamine oxidase inhibitors

5. Metabotropic glutamate receptors in the basal ganglia motor circuit

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting mGluR group III for the treatment of neurodegenerative diseases;Biomedicine & Pharmacotherapy;2023-12

2. Targeting Striatal Glutamate and Phosphodiesterases to Control L-DOPA-Induced Dyskinesia;Cells;2023-11-30

3. Structural insights into dimerization and activation of the mGlu2–mGlu3 and mGlu2–mGlu4 heterodimers;Cell Research;2023-06-08

4. Biophysical Dissection of Isolated GPCRs: The Adenosine A2A Receptor under the Bistouries;Receptors;2023-02-04

5. How and why the adenosine A2A receptor became a target for Parkinson’s disease therapy;International Review of Neurobiology;2023